ArQule Competitors and Similar CompaniesClear all
ArQule's competitors and similar companies include Hutchison China Meditech, Moderna, Ajinomoto Bio-Pharma Services and RaQualia Pharma.
 ArQule ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases. |  Hutchison China Meditech Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products. |  Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine. |  Ajinomoto Bio-Pharma Services Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO). |  RaQualia Pharma RaQualia Pharma (ラクオリア創薬) is a pharmaceutical company specializing in drug discovery research. | |
Founding Date | Founding Date 1993 | Founding Date 2000 | Founding Date 2010 | Founding Date 1998 | Founding Date 2008 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Burlington, US HQ | Locations Shanghai, CN HQ Beijing, CN Jiangsu, CN Shanghai, CN Shanghai, CN Hong Kong, HK Hong Kong, HK see more | Locations San Diego, US HQ Wetteren, BE Visakhapatnam, IN Osaka, JP | Locations Nagoya, JP HQ | |
Employees | Employees 3613% increase | Employees 1,811 | Employees 5,8004% increase | Employees 68610% decrease | Employees 264% increase |
Valuation ($) | Valuation ($) 2.4 b | Valuation ($) 3.6 b | Valuation ($) 21.2 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $548.5m (FY, 2025) | Revenue (est.) $1.9b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $324.4m (FY, 2025) | Cost of goods $868m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $224.2m (FY, 2025) | Gross profit $1.1b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($15.5m) (FY, 2018) | Net income $435.1m (FY, 2025) | Net income ($2.8b) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 100m | Total funding raised $ 1.8b | Total funding raised $ 3.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Hutchison China Meditech
HQ
Shanghai, CN
Employees
1,811
Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.
View companyModerna
HQ
Cambridge, US
Employees
5,800↑ 4% increase
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
View companyAjinomoto Bio-Pharma Services
HQ
San Diego, US
Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO).
View companyRaQualia Pharma
HQ
Nagoya, JP
Employees
26↑ 4% increase
RaQualia Pharma (ラクオリア創薬) is a pharmaceutical company specializing in drug discovery research.
View company